Literature DB >> 17384493

Successful use of prolonged mild hypothermia in a patient with severe head injury and diffuse brain swelling. Case report.

Mamoru Murakami1, Tetsuya Tsukahara, Hiroyasu Ishikura, Taketo Hatano, Takuya Nakakuki, Eiji Ogino, Takako Aoyama.   

Abstract

A 19-year-old female was admitted to our hospital after severe head injury in a traffic accident. On admission, she had no spontaneous respiration, but did have heart beat with a blood pressure of 100/60 mmHg. Neurological examination demonstrated that the Glasgow Coma Scale score was 3 and her pupils were fixed and dilated. Computed tomography (CT) showed diffuse brain swelling with disappearance of the perimesencephalic cistern. Chest CT showed bilateral lung contusions. Mild hypothermia with a target temperature of 33 degrees C was immediately induced, and was continued for 28 days to control the persistent increase in intracranial pressure (ICP). Subsequently, she recovered, and 20 months after admission, could speak and walk with slight hemiparesis on the left. Prolonged mild hypothermia may be effective to control persistent increase in ICP due to diffuse brain swelling.

Entities:  

Mesh:

Year:  2007        PMID: 17384493     DOI: 10.2176/nmc.47.116

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  3 in total

1.  Effect of prolonged therapeutic hypothermia on intracranial pressure, organ function, and hospital outcomes among patients with aneurysmal subarachnoid hemorrhage.

Authors:  Lioudmila V Karnatovskaia; Augustine S Lee; Emir Festic; Christopher L Kramer; William D Freeman
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

2.  Prolonged Mild-to-Moderate Hypothermia for Refractory Intracranial Hypertension.

Authors:  H Kee Ng; Ra Hanel; Wd Freeman
Journal:  J Vasc Interv Neurol       Date:  2009-01

3.  Recent advances and future directions of hypothermia therapy for traumatic brain injury.

Authors:  Eiichi Suehiro; Hiroyasu Koizumi; Yuichi Fujiyama; Michiyasu Suzuki
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-10-31       Impact factor: 1.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.